| 1. |
Fung AT, Yang Y, Kam AW. Central serous chorioretinopathy: a review[J]. Clin Exp Ophthalmol, 2023, 51(3): 243-270. DOI: 10.1111/ceo.14201.
|
| 2. |
Araki T, Ishikawa H, Iwahashi C, et al. Central serous chorioretinopathy with and without steroids: a multicenter survey[J/OL]. PloS One, 2019, 14(2): e213110[2019-02-28]. https://pubmed.ncbi.nlm.nih.gov/30818363/. DOI: 10.1371/journal.pone.0213110.
|
| 3. |
Carvalho-Recchia CA, Yannuzzi LA, Negrão S, et al. Corticosteroids and central serous chorioretinopathy[J]. Ophthalmology, 2002, 109(10): 1834-1837. DOI: 10.1016/s0161-6420(02)01117-x.
|
| 4. |
van Dijk EH, Dijkman G, Biermasz NR, et al. Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome[J]. Eur J Ophthalmol, 2016, 26(5): 442-448. DOI: 10.5301/ejo.5000790.
|
| 5. |
Kaye R, Chandra S, Sheth J, et al. Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities[J/OL]. Prog Retin Eye Res, 2020, 79: 100865[2020-05-11]. https://pubmed.ncbi.nlm.nih.gov/32407978/. DOI: 10.1016/j.preteyeres.2020.100865.
|
| 6. |
Levy J, Marcus M, Belfair N, et al. Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy[J]. Can J Ophthalmol, 2005, 40(2): 217-221. DOI: 10.1016/S0008-4182(05)80040-7.
|
| 7. |
Clarke C, Smith SV, Lee AG. A rare association: Cushing disease and central serous chorioretinopathy[J/OL]. Can J Ophthalmol, 2017, 52(2): e77-e79[2016-10-27]. https://pubmed.ncbi.nlm.nih.gov/28457311/. DOI: 10.1016/j.jcjo.2016.09.002.
|
| 8. |
陈曦, 刘庆淮. 中心性浆液性脉络膜视网膜病变与相关激素水平变化的研究现状[J]. 中华眼底病杂志, 2011, 27(4): 397-400. DOI: 10.3760/cma.j.issn.1005-1015.2011.04.032.Chen X, Liu QH. Research status of central serous chorioretinopathy and changes of related hormone levels[J]. Chin J Ocul Fundus Dis, 2011, 27(4): 397-400. DOI: 10.3760/cma.j.issn.1005-1015.2011.04.032.
|
| 9. |
Iannetti L, Spinucci G, Pesci FR, et al. Central serous chorioretinopathy as a presenting symptom of endogenous Cushing syndrome: a case report[J]. Eur J Ophthalmol, 2011, 21(5): 661-664. DOI: 10.5301/EJO.2011.6449.
|
| 10. |
Pastor-Idoate S, Peña D, Herreras JM. Adrenocortical adenoma and central serous chorioretinopathy: a rare association?[J]. Case Rep Ophthalmol, 2011, 2(3): 327-332. DOI: 10.1159/000333556.
|
| 11. |
Takkar B, Temkar S, Gaur N, et al. Central serous retinopathy as presentation of an adrenal adenoma[J/OL]. BMJ Case Rep, 2018, 11(1): e227315[2018-12-14]. https://pubmed.ncbi.nlm.nih.gov/30567268/. DOI: 10.1136/bcr-2018-227315.
|
| 12. |
叶娅, 宋艳萍, 闫明. 肾上腺腺瘤致浆液性脉络膜视网膜病变合并渗出性视网膜脱离一例[J]. 中华眼科杂志, 2021, 57(10): 784-786. DOI: 10.3760/cma.j.cn112142-20210728-00355.Ye Y, Song YP, Yan M. Adrenal adenoma presenting as serous chorioretinopathy complicated by exudative retinal detachment: a case report[J]. Chin J Ophthalmol, 2021, 57(10): 784-786. DOI: 10.3760/cma.j.cn112142-20210728-00355.
|
